Serpass Biologics, Dr. Lucas’ startup, is developing a new class of immune-modulating biologics for autoimmune disorders. These can be used to treat and suppress excessive immune system responses in a wide range of diseases, including arthritic, cardiac, gastrointestinal, pulmonary and vascular disorders.
The annual competition is run by Skysong Innovations, which works across the university to help researchers pursue commercial applications for their work.
Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings.
Clearance supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days Pristine™ Long-Term Hemodialysis Catheter
The Flinn Foundation hosted its annual bioscience event April 14 to share the impressive progress of Arizona’s growing sector nearly two decades since the launch of Arizona’s Bioscience Roadmap.
The virtual event featured a keynote address by Tom Osha of Wexford Science and Technology and a mix of live presentations and videos showcasing the innovative and growing bioscience ecosystem throughout Arizona, including Flagstaff, metro Phoenix, and the Tucson and Yuma regions. Continue reading
Applications for the 2021 FCC Telehealth Program are expected to open soon. Life365 is providing information and resources to help qualified healthcare organizations get started with their applications.
Continue reading
Boosting ABCC1 could lessen the production of plaque linked to Alzheimer’s development
PHOENIX, Ariz. — April 13, 2021 — Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ABCC1 could not only reduce the deposition of a hard plaque in the brain that leads to Alzheimer’s disease, but might also prevent or delay this memory-robbing disease from developing.
The Arizona Health Care Cost Containment System (AHCCCS), in partnership with Crisis Response Network, announces a new COVID-19 appointment and transportation navigation program for Medicaid members. Now, Medicaid members who need assistance scheduling a COVID-19 vaccine appointment, as well as transportation to and from that appointment, can call 1-844-542-8201, 8 a.m. to 5 p.m., seven days a week.Continue reading
PHOENIX–(BUSINESS WIRE)–Calviri announces the appointment of Marc Wolff as Chief Executive Officer. Founder and current CEO, Stephen Albert Johnston, will continue to serve as Chairman of the Board of Directors and Founding CEO.Continue reading
New patient-level data will facilitate more efficient clinical trial design